News Archive

News Archive

Novel genes identified that help suppress prostate and other cancers

HomePage_Anne_Weston_LRI_CRUK_Wellcome_Images.jpg

Novel genes identified that help suppress prostate and other cancers

Study reveals possible drug targets for cancers with a faulty PTEN gene

Cooperating genes and pathways found for tumour suppressor gene PTEN. These are possible drug targets for cancers with a faulty PTEN gene.

1 in 5 patients with breast cancer could benefit from existing treatment, genetic study reveals

BRCAHomepage.jpg

1 in 5 patients with breast cancer could benefit from existing treatment, genetic study reveals

Study shows that a greater number of breast cancers are genetically similar to rarer cases with faulty BRCA1 or BRCA2 genes

Researchers from the Wellcome Trust Sanger Institute and their collaborators have discovered that a greater number of breast cancers are genetically similar to rarer cases with faulty BRCA1 or BRCA2 genes. The results published today (13 March) in Nature Medicine open up the possibility of up to 20 per cent of women being treated with PARP inhibitors, a class of drug previously only thought to be effective for women with an inherited BRCA1 or BRCA2 mutation.

Matt Hurles appointed as new Head of Human Genetics Programme

hurles.jpg

Matt Hurles appointed as new Head of Human Genetics Programme

Dr Matt Hurles, leader of the DDD Programme and co-founder of Institute spin-out Congenica, has been confirmed as the new Head of the Human Genetics Programme

On Tuesday 7 March Dr Matt Hurles accepted the permanent position of Head of the Human Genetics Programme. Dr Hurles joined the Sanger Institute in 2003 as a member of Faculty to pursue his interest in understanding the genetic causes underlying severe developmental disorders, and understanding how DNA mutations arise as it is passed from generation to generation.

Role models recognised for supporting women in science

biggroup.jpg

Role models recognised for supporting women in science

Eleftheria Zeggini of the Wellcome Trust Sanger Institute and Helen Parkinson of the European Bioinformatics Institute (EMBL-EBI) have been recognised for their work in promoting gender equality on the Wellcome Genome Campus

Two staff members were recognised by Mike Stratton, Ewan Birney and Rolf Apweiler today, International Women’s Day (8 March) for their efforts in supporting women in science, in the third annual Wellcome Genome Campus Best Practice Award.

Latest genomic technology uncovers secrets of immune system's response to malaria

homepage.png

Latest genomic technology uncovers secrets of immune system's response to malaria

Scientists reveal how mouse T cells develop

Scientists have revealed for the first time how immature mouse immune cells, called T cells, choose which type of skills they will develop to fight malaria infection. Reported in Science Immunology, researchers tracked individual T cells during infection with malaria parasites. They discovered a whole network of chemical conversations between different types of cells that influenced T cell specialisation.

Sanger parasite researcher recognised by British Parasitology Society

medalindex.png

Sanger parasite researcher recognised by British Parasitology Society

Dr Matthew Berriman awarded the 2017 CA Wright Medal for his leading role in understanding protozoan and helminthic parasites through genomics

Dr Berriman, a senior group leader within the Wellcome Trust Sanger Institute, has played a leading role in the sequencing of genomes from protozoan and helminthic parasites as well as the application of these data in the study of parasite biology, genetics, evolution and adaptation to parasitism. The award of the CA Wright Medal recognises the impact of Dr Berriman’s research in placing British parasitology at the forefront of international efforts to tackle the health burden attributed to parasitic disease.

Sanger Institute's COSMIC database expands cancer cloud capabilities at the Institute for Systems Biology

testlogo.png

Sanger Institute's COSMIC database expands cancer cloud capabilities at the Institute for Systems Biology

The Institute for Systems Biology has embedded the COSMIC data within their Cancer Genomics Cloud (CGC), which is a cloud-based platform that uses Google BigQuery technology to bring unprecedented computing power to researchers around the world

The Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC) team announces a new agreement to provide their data to the U.S.-based Institute for Systems Biology (ISB).

Sanger scientists win £20 million ‘Grand Challenge’ funding from Cancer Research UK

Main-Website-image.jpg

Sanger scientists win £20 million ‘Grand Challenge’ funding from Cancer Research UK

Professor Sir Mike Stratton will lead an international team to help transform our understanding of what causes cancer

The first Cancer Research UK Grand Challenge Project seeks to fill in the missing gaps to identify unknown cancer-causing factors and reveal how they lead to cancer. To do this 5,000 pancreatic, kidney, oesophageal and bowel cancer patients, from five continents will be studied and compared.

Malaria vaccine target’s invasion partner uncovered

Sanger_malaria_RH5_P113_3_website_banner.png

Malaria vaccine target’s invasion partner uncovered

This could help develop a more effective malaria vaccine

Researchers discover how a promising malarial vaccine target - the protein RH5 - uses a previously mysterious protein P113 to create a bridge between the parasite and red blood cell.

Pages